Geri
VISEN Pharmaceuticals (02561.HK) Fiyatı
02561.HK Hisse Senedi Fiyat Grafiği
VISEN PHARMA-B (02561.HK)
VISEN Pharmaceuticals
HK$34.2
-0.86%
$-0.29
Normal Piyasa: Jan 21, 16:34:55 HKT
Henüz Veri YokFollow-Up Questions
VISEN Pharmaceuticals'in temel mali tabloları nelerdir?
02561.HK'ün temel finansal oranları nelerdir?
VISEN Pharmaceuticals'in geliri segment veya coğrafya bazında nasıl dağılıyor?
VISEN Pharmaceuticals kârlı mı?
VISEN Pharmaceuticals'in herhangi bir yükümlülüğü var mı?
VISEN Pharmaceuticals'in tedavüldeki hisse sayısı kaçtır?
Önemli İstatistikler
Önceki Kapanış
$34.5
Açılış fiyatı
$34.5
Günün Aralığı
$34 - $34.52
52 haftalık aralık
$29.06 - $69.15
İşlem hacmi
7.2K
Ort.Hacim
33.2K
EPS (TTM)
-2.11
Dividend yield
--
Piyasa Değeri
$3.8B
VISEN PHARMA-B nedir?
VISEN Pharmaceuticals operates as a biopharmaceutical company. The company is headquartered in Suzhou, Jiangsu and currently employs 54 full-time employees. The company went IPO on 2025-03-21. The firm's main products under development include lonapegsomatropin, navepegritide, and palopegteriparatide. The lonapegsomatropin is used to treat growth hormone deficiency in children aged 3 to 17 years old. The navepegritide is a disease repair therapy used to treat children with cartilage dysplasia aged 2 to 10 years old. The palopegteriparatide is a treatment method used to treat adult hypoparathyroidism. The firm is in the late stage of research and development, and its products are close to commercialization.
Özellikler
Ticaret Stratejileri
Kaynaklar
© 2025 Finture Development Limited. All rights reserved